Cwm LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 117,358 shares of the healthcare conglomerate's stock after purchasing an additional 8,877 shares during the quarter. Cwm LLC's holdings in UnitedHealth Group were worth $61,466,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $42,000. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $41,000. Institutional investors own 87.86% of the company's stock.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.
Analyst Upgrades and Downgrades
UNH has been the topic of a number of research analyst reports. HSBC restated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. KeyCorp decreased their price target on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Finally, Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $415.00.
Read Our Latest Research Report on UNH
UnitedHealth Group Price Performance
NYSE:UNH opened at $303.81 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock's 50-day simple moving average is $314.52 and its 200 day simple moving average is $440.43. The company has a market cap of $275.60 billion, a P/E ratio of 12.72, a P/E/G ratio of 1.46 and a beta of 0.45. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.